WEDNESDAY, SEPTEMBER 28, 2016

New study shows Novirin, Gene-Eden-VIR can prevent, treat herpes virus

The Center for the Biology of Chronic Disease recommends natural antiviral dietary supplements Novirin and Gene-Eden-VIR for those infected with herpes.

This recommendation comes on the heels of the vaccine showing positive results in a recent phase 1 trial conducted by Dr. Ian Frazer and endorsed by David Rhodes, the science officer of the Australian healthcare group Admedus.

“The primary goal of the new vaccine was not to prevent the spread of herpes simplex, but to treat it,” Rhodes said.

Results of the study showed that the new herpes vaccine produced a T-cell response in 95 percent of the humans it was tested on. Moving forward, trials will be extended to test whether the vaccine also works to not only prevent the spread of the virus but to also have a larger sample size.

The formula of Novirin and Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the CBCD, with the studies showing that the Novirin and Gene-Eden-VIR formula is effective against the herpes simplex virus. The findings were published in a recent issue of Pharmacology and Pharmacy.

Novirin and Gene-Eden-VIR contain five natural ingredients – selenium, camellia sinesis extract, quercetin, cinnamomum extract and licorice extract.

“The very encouraging results, clean safety profile and cellular immune responses demonstrated in this HSV-2 study are particularly encouraging and validate the potential of our range of therapeutic vaccines which utilizes Professor Frazer’s novel immunotherapy technology,” Admedus CEO Lee Rodne said.